Nanoportal Biotech

Nanoportal Biotech is a private gene delivery biotechnology company focused on coacervate-based intracellular delivery technologies built from mammalian endogenous proteins. Its core EASY platform is designed to deliver nucleic acids, proteins, small molecules, and other cargoes into difficult primary cells and hard-to-transfect cell types, with current commercial activity centered on the ProteanFect transfection reagent family for research use. The company is also positioning the platform for broader applications in gene therapy and cell therapy manufacturing, including CAR-T, NK cell, and hematopoietic stem cell engineering. Based on its public materials, Nanoportal appears to be primarily a platform and enabling-technology company rather than a clinical-stage therapeutics developer at this time.